Grant: Discovery Grants Program - Individual
Université de Montréal
$57,000.00
Chemi-enzymatic and data mining approaches for the identification of post-translational modifications
FY 2011-12
Summary
Post-translational modifications (PTMs) of proteins play an intrinsic role in modulating numerous cellular activities including protein translocation, turnover, and interaction with binding partners. In human cells, the covalent attachment of more than 200 types of PTMs is carried out by dedicated enzymes representing about 5 % of the genome. Several of them including kinases, ubiquitin- and small ubiquitin-like modifier (SUMO) enzymes are misregulated in cancer cells, thus representing putative targets for drug discovery and cancer research programs. The functional correlation of these enzymes with phenotypic changes associated with tumorigenesis requires comprehensive profiling of PTMs at the genomic-scale, a daunting task given their diversity, stoichiometry and low distribution frequency within protein structures and cell extracts. In this context, mass spectrometry (MS) has proven to be an essential analytical tool providing sensitive and specific identification of PTMs from complex cell extracts. Our research program ""Chemi-enzymatic and data mining approaches for the identification of PTMs"" builds upon recent advances from our group in large-scale quantitative MS-based proteomics to profile protein modifications from affinity-enriched biological extracts. As part of this proposal, we will develop specific enrichment and digestion strategies together with targeted MS detection approaches for the identification of protein phosphorylation and sumoylation; two modifications of significant interest in cell signaling and cancer research. The tools developed will be applied in the study of cancer cell model systems to identify novel substrates and to unravel networks of interacting proteins modulated by chemical stimulants, kinase inhibitors and known chromosomal translocations associated with leukemia. More importantly, analytical tools developed in this proposal will be of broader application to any large-scale proteomics and drug discovery programs investigating protein-drug interactions and cell signaling events for the development of better targeted medicines ultimately improving human health.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
311598-2008
Name nom
Thibault, Pierre
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2008
Award amount
57000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
26
Committee name en
Anal. & Phys. Chemistry
Committee name fr
Chimie analytique et physique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
4
Nb partie
5
Application title
Chemi-enzymatic and data mining approaches for the identification of post-translational modifications
Keyword
NSERC
Application summary
Post-translational modifications (PTMs) of proteins play an intrinsic role in modulating numerous cellular activities including protein translocation, turnover, and interaction with binding partners. In human cells, the covalent attachment of more than 200 types of PTMs is carried out by dedicated enzymes representing about 5 % of the genome. Several of them including kinases, ubiquitin- and small ubiquitin-like modifier (SUMO) enzymes are misregulated in cancer cells, thus representing putative targets for drug discovery and cancer research programs. The functional correlation of these enzymes with phenotypic changes associated with tumorigenesis requires comprehensive profiling of PTMs at the genomic-scale, a daunting task given their diversity, stoichiometry and low distribution frequency within protein structures and cell extracts. In this context, mass spectrometry (MS) has proven to be an essential analytical tool providing sensitive and specific identification of PTMs from complex cell extracts. Our research program ""Chemi-enzymatic and data mining approaches for the identification of PTMs"" builds upon recent advances from our group in large-scale quantitative MS-based proteomics to profile protein modifications from affinity-enriched biological extracts. As part of this proposal, we will develop specific enrichment and digestion strategies together with targeted MS detection approaches for the identification of protein phosphorylation and sumoylation; two modifications of significant interest in cell signaling and cancer research. The tools developed will be applied in the study of cancer cell model systems to identify novel substrates and to unravel networks of interacting proteins modulated by chemical stimulants, kinase inhibitors and known chromosomal translocations associated with leukemia. More importantly, analytical tools developed in this proposal will be of broader application to any large-scale proteomics and drug discovery programs investigating protein-drug interactions and cell signaling events for the development of better targeted medicines ultimately improving human health.